Copyright: ©Author(s) 2026.
World J Gastroenterol. Dec 21, 2026; 32(47): 122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Published online Dec 21, 2026. doi: 10.3748/wjg.122668
Figure 6 ZFP36 inhibited tumor growth in vivo.
A: Xenografts were established in nude mice using AGS cells and resected 63 days post-induction; B: Tumor volumes were calculated at indicated time points (days 7, 15, 21, 36, 44, 51, 55, 59, and 63) using the formula: V = (L × S2)/2, where L = long diameter and S = short diameter; C: Xenograft weights were measured following resection; D: Resected tumor volumes were quantified; E: Lipase G protein expression levels in xenograft tissues were assessed. bP < 0.01. LIPG: Lipase G; NC: Negative control; OE: Overexpression.
- Citation: Yu PJ, Zhu SM, Cai BJ, Ma XM, Qiao WJ, Han JJ, Zhang CW. Zfp36 zinc finger CCCH-type inhibits gastric cancer progression by upregulating lipase G and binding its 3’ untranslated region. World J Gastroenterol 2026; 32(47): 122668
- URL: https://www.wjgnet.com/1007-9327/full/v32/i47/122668.htm
- DOI: https://dx.doi.org/10.3748/wjg.122668